Cargando...
Gene Therapy for Human Sensorineural Hearing Loss
Hearing loss is the most common sensory impairment in humans and currently disables 466 million people across the world. Congenital deafness affects at least 1 in 500 newborns, and over 50% are hereditary in nature. To date, existing pharmacologic therapies for genetic and acquired etiologies of dea...
Guardado en:
| Publicado en: | Front Cell Neurosci |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6660246/ https://ncbi.nlm.nih.gov/pubmed/31379508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2019.00323 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|